Follow the company. Check the evidence.
Public records connected to stocks traded by Congress. See what changed, when it became public, and the original source.
AMGN: second_quarter 2026 lobbying report
Issues related to visas Healthcare policy issues as they relate to the pharmaceutical industry including drug pricing and biosimilars Issues related to drug pricing, biosimilars, Medicare Part D and Medicare Part B; H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021
Public: Jul 20, 2026, 11:17 AM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
AMGN: second_quarter 2026 lobbying report
Issues related to Medicare and Medicaid drug pricing; Issues related to biosimilar access and affordability. Issues related to the 340B Program - Public Health Service Act (PL 78-410); Issues related to H.R. 5526/S. 1954 - Biosimilar Red Tape Elimination Act.
Public: Jul 19, 2026, 3:45 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
AMGN: second_quarter 2026 lobbying report
Monitor healthcare regulations and statutes and educate members of Congress on issues with regard to client's interests
Public: Jul 19, 2026, 3:14 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
AMGN: second_quarter 2026 lobbying report
Lobbying related to pharmaceutical policy and health care access Lobbying related to pharmaceutical policy and Medicare policy federal budget issues
Public: Jul 16, 2026, 5:24 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
AMGN: second_quarter 2026 lobbying report
Medicare Part B coverage and reimbursement issues; Medicare Part D coverage issues. AI in health care. 340B Program issues.
Public: Jul 16, 2026, 5:08 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
AMGN: second_quarter 2026 lobbying report
Issues related to health access. PBM reform. Most Favored Nation issues. 340B Reform. Issues related to Womens Health
Public: Jul 16, 2026, 12:16 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
AMGN: second_quarter 2026 lobbying report
Issues related to the pharmaceutical industry.
Public: Jul 10, 2026, 12:10 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
AMGN: second_quarter 2026 lobbying report
Monitor healthcare regulations and statutes and educate members of Congress on issues with regard to client's interests
Public: Jun 12, 2026, 5:07 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
AMGN: second_quarter 2026 lobbying report
Educating members on issues affecting Amgen and patients
Public: Jun 12, 2026, 5:05 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
AMGN: first_quarter 2026 lobbying report
Issues related to the implementation of the Medicare Drug Negotiations and the calculation of the Medicaid Rebate and Best Price. issues relating to MFN pricing and other price controls in drugs.
Public: Jun 2, 2026, 7:20 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
AMGN: second_quarter 2026 lobbying report
Issues related to drug pricing and reimbursement for prescription drugs.
Public: Jun 1, 2026, 4:00 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
Connections describe public records, not evidence of wrongdoing or a prediction of returns. Event dates can precede publication by days or months. When a source has no public-release timestamp, we show when we first observed it.
Source coverage
Coverage is growing across companies already tracked here. A scan can return no matching records. This feed is not a complete record of every filing or agency action.
- SEC EDGAR
- Partial coverage — some requests unavailable455 of 455 companies scanned in the past 12 hoursLatest successful company scan: Nov 8, 2026, 11:56 PM EST
- USAspending
- Partial coverage — some requests unavailable285 of 495 companies scanned in the past 12 hoursLatest successful company scan: Nov 8, 2026, 11:48 PM EST
- SAM.gov
- Not connected
- Lobbying disclosures
- Partial coverage — some requests unavailable75 of 495 companies scanned in the past 12 hoursLatest successful company scan: Nov 8, 2026, 11:29 PM EST
- Congress.gov
- Current across tracked companies2 of 2 companies scanned in the past 12 hoursLatest successful company scan: Nov 8, 2026, 11:17 PM EST
- Federal Register
- Partial coverage — some requests unavailable387 of 495 companies scanned in the past 12 hoursLatest successful company scan: Nov 8, 2026, 11:49 PM EST
- Regulations.gov
- Partial coverage — some requests unavailable24 of 51 companies scanned in the past 12 hoursLatest successful company scan: Nov 8, 2026, 11:49 PM EST
- FEC campaign finance
- Stale — refresh overdue264 of 495 companies scanned in the past 12 hoursLatest successful company scan: Nov 8, 2026, 11:49 PM EST